Identification of candidates for coronary artery bypass grafting admitted with STEMI and Multivessel Disease

被引:6
|
作者
Rodriguez-Olivares, Ramon [1 ,2 ]
Lopez-Menendez, Jose [3 ]
Varela Barca, Laura [3 ]
Miguelena Hycka, Javier [3 ]
Hernandez-Antolin, Rosana [1 ,2 ]
Rodriguez-Roda Stuart, Jorge [3 ]
Zamorano Gomez, Jose L. [1 ,2 ]
机构
[1] Ramon y Cajal Univ Hosp, Dept Cardiol, Ctra Colmenar Viejo,Km 9,100, Madrid 28034, Spain
[2] Ctr Invest Blomed Red Cardiovasc CIBERCV, Madrid, Spain
[3] Raman y Cajal Univ Hosp, Dept Cardiac Surg, Madrid, Spain
关键词
STEMI; Multivessel coronary artery disease; CABG;
D O I
10.1016/j.carrev.2018.06.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The optimal management of patients with multivessel coronary artery disease (MVD) admitted with STEMI is under debate. CABG is rarely performed, even on ideal candidates. A provisional PCI without stent implantation may allow complete surgical revascularization (CSR) in a subset of patient that we sought to identify in this study. Methods: Patients with STEMI from April 2014 to October 2016 were evaluated and those with a TIMI flow <3 in the culprit vessel, and an additional stenosis of >70% in an epicardial vessel or sidebranch >2.5 mm were selected. Epidemiological variables, surgical risk scores and SYNTAX and SYNTAX II scores were analyzed. All the selected patients were discussed in a post hoc heart-team, and predictors of 12-month events were also analyzed. Results: Seventy-two (19.0%) accomplished MVD criteria. Mean SYNTAX was 19 +/- 13 points and SYNTAX II score recommended CABG in 12 patients (16.7%) and heart-team discussion in 60 (83.3%). All patients were discussed in a post hoc heart-team, which concluded that 21 (29.2%) patients could have been good candidates for CSR. After one year follow-up, SYNTAX II PCI > 40 was found to be the sole independent predictor for 12-month events (OR 12.9[2.7-62.1], p = 0.001). Conclusions: MVD and STEMI with a SYNTAX II PCI > 40 should be discussed in an ad-hoc heart team, after a provisional revascularization of the culprit vessel, and should be considered for CSR, especially when the RCA is the culprit artery and there is a complex disease in the left coronary artery. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:S21 / S26
页数:6
相关论文
共 50 条
  • [41] Comparison of hybrid coronary revascularization versus coronary artery bypass grafting in patients with multivessel coronary artery disease: a meta-analysis
    Yu, Li
    Zhu, Keying
    Du, Nannan
    Si, Yuexiu
    Liang, Jiali
    Shen, Ruijing
    Chen, Bangsheng
    JOURNAL OF CARDIOTHORACIC SURGERY, 2022, 17 (01)
  • [42] COMPARISON OF PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY VERSUS CORONARY-ARTERY BYPASS-GRAFTING FOR MULTIVESSEL CORONARY-ARTERY DISEASE
    VACEK, JL
    ROSAMOND, TL
    STITES, HW
    ROWE, SK
    ROBUCK, W
    DITTMEIER, G
    BEAUCHAMP, GD
    AMERICAN JOURNAL OF CARDIOLOGY, 1992, 69 (06): : 592 - 597
  • [43] Coronary Artery Bypass grafting (CABG) versus Percutaneous Coronary Intervention (PCI) in the treatment of multivessel coronary disease: A review
    Al Ansari, Ahmed Ebrahim
    Alzahrani, Hassan Ali
    Alqulayti, Waad Maher
    Rawah, Maram Adnan
    Alnajjar, Leena Lotfy
    Subedar, Alaa Tarek M.
    Aloufi, Banan Matuq M.
    Ajwah, Ibrahim Mahmoud H.
    Albalawi, Abdulaziz Abdullah M.
    Aljohani, Khalid Mohammed A.
    Albalawi, Abdulrahman Mohammed K.
    Aljoaid, Shahad Saad A.
    Alatawi, Raya Abdullah S.
    Alsaiari, Afnan Saleh M.
    Alrefai, Lamia Mohammed S.
    Hameed, Abdulrahman Muneer H.
    Al Masoud, Dalal Khalid H.
    Alsada, Ali Mohamed S.
    AUSTRALASIAN MEDICAL JOURNAL, 2021, 14 (04): : 124 - 128
  • [44] Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease
    Hannan, Edward L.
    Wu, Chuntao
    Walford, Gary
    Culliford, Alfred T.
    Gold, Jeffrey P.
    Smith, Craig R.
    Higgins, Robert S. D.
    Carlson, Russell E.
    Jones, Robert H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (04): : 331 - 341
  • [45] NEUTRALIZATION OF THE INCREASED RISK OF MULTIVESSEL AND LEFT MAIN CORONARY-ARTERY DISEASE BY CORONARY-ARTERY BYPASS-GRAFTING
    KIRKLIN, JW
    BLACKSTONE, EH
    PACIFICO, AD
    ZORN, GL
    KIRKLIN, JK
    ROGERS, WJ
    CIRCULATION, 1984, 70 (04) : 104 - 104
  • [46] Drug-Eluting Stents versus Coronary-Artery Bypass Grafting for Multivessel Coronary Artery Disease in Patients With Diabetes
    Li, Yan
    Zheng, Zhe
    Xu, Bo
    Zhang, Shiju
    Li, Wei
    Gao, Runlin
    Hu, Shengshou
    CIRCULATION, 2009, 120 (18) : S983 - S983
  • [47] Multivessel coronary artery disease and poor left ventricle function: It is consistent and clear, coronary artery bypass grafting wins again
    Attaran, Saina
    Weintraub, William S.
    Thourani, Vinod H.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 156 (04): : 1406 - 1407
  • [48] Hybrid Coronary Revascularization and Coronary Artery Bypass Grafting: A Comparison of Multivessel Coronary Revascularization Strategies
    Lawler, T.
    Stone, B.
    Ahmad, S.
    Panza, A.
    Louis, L.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2024, 17 (04) : S26 - S26
  • [49] Comparison of Drug-Eluting Stents and Coronary Artery Bypass Grafting for the Treatment of Multivessel Coronary Artery Disease in Patients With Chronic Kidney Disease
    Wang, Zhi Jian
    Zhou, Yu Jie
    Liu, Yu Yang
    Shi, Dong Mei
    Zhao, Ying Xin
    Guo, Yong He
    Cheng, Wan Jun
    Yu, Miao
    CIRCULATION JOURNAL, 2009, 73 (07) : 1228 - 1234
  • [50] Complete Revascularization in Patients With STEMI and Multivessel Coronary Artery Disease: Is It Beneficial?
    Voudris, Konstantinos V.
    Feldman, Dmitriy N.
    CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2021, 23 (02)